302 related articles for article (PubMed ID: 31932215)
21. The adipokine lipocalin-2 in the context of the osteoarthritic osteochondral junction.
Villalvilla A; García-Martín A; Largo R; Gualillo O; Herrero-Beaumont G; Gómez R
Sci Rep; 2016 Jul; 6():29243. PubMed ID: 27385438
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end-products increase lipocalin 2 expression in human oral epithelial cells.
Kido R; Hiroshima Y; Kido JI; Ikuta T; Sakamoto E; Inagaki Y; Naruishi K; Yumoto H
J Periodontal Res; 2020 Aug; 55(4):539-550. PubMed ID: 32170733
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications.
Bhusal A; Rahman MH; Lee WH; Bae YC; Lee IK; Suk K
Biochem Pharmacol; 2019 Nov; 169():113626. PubMed ID: 31476294
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
[TBL] [Abstract][Full Text] [Related]
26. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Chiang KC; Yeh TS; Wu RC; Pang JS; Cheng CT; Wang SY; Juang HH; Yeh CN
Sci Rep; 2016 Oct; 6():36138. PubMed ID: 27782193
[TBL] [Abstract][Full Text] [Related]
27. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
28. LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer.
Zhao H; Ding F; Zheng G
FASEB J; 2020 Sep; 34(9):11382-11394. PubMed ID: 32692467
[TBL] [Abstract][Full Text] [Related]
29. Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.
Mike EV; Makinde HM; Gulinello M; Vanarsa K; Herlitz L; Gadhvi G; Winter DR; Mohan C; Hanly JG; Mok CC; Cuda CM; Putterman C
J Autoimmun; 2019 Jan; 96():59-73. PubMed ID: 30174216
[TBL] [Abstract][Full Text] [Related]
30. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
[TBL] [Abstract][Full Text] [Related]
31. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
Kim SL; Min IS; Park YR; Lee ST; Kim SW
Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
[TBL] [Abstract][Full Text] [Related]
32. Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia.
Kim JH; Ko PW; Lee HW; Jeong JY; Lee MG; Kim JH; Lee WH; Yu R; Oh WJ; Suk K
Glia; 2017 Sep; 65(9):1471-1490. PubMed ID: 28581123
[TBL] [Abstract][Full Text] [Related]
33. Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments.
Shibata K; Sato K; Shirai R; Seki T; Okano T; Yamashita T; Koide A; Mitsuboshi M; Mori Y; Hirano T; Watanabe T
Heart Vessels; 2020 Jul; 35(7):1012-1024. PubMed ID: 31960147
[TBL] [Abstract][Full Text] [Related]
34. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.
Santiago-Sánchez GS; Pita-Grisanti V; Quiñones-Díaz B; Gumpper K; Cruz-Monserrate Z; Vivas-Mejía PE
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575507
[TBL] [Abstract][Full Text] [Related]
35. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation.
Moschen AR; Adolph TE; Gerner RR; Wieser V; Tilg H
Trends Endocrinol Metab; 2017 May; 28(5):388-397. PubMed ID: 28214071
[TBL] [Abstract][Full Text] [Related]
36. Sex-specific metabolic functions of adipose Lipocalin-2.
Chella Krishnan K; Sabir S; Shum M; Meng Y; Acín-Pérez R; Lang JM; Floyd RR; Vergnes L; Seldin MM; Fuqua BK; Jayasekera DW; Nand SK; Anum DC; Pan C; Stiles L; Péterfy M; Reue K; Liesa M; Lusis AJ
Mol Metab; 2019 Dec; 30():30-47. PubMed ID: 31767179
[TBL] [Abstract][Full Text] [Related]
37. Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice.
Ishii A; Katsuura G; Imamaki H; Kimura H; Mori KP; Kuwabara T; Kasahara M; Yokoi H; Ohinata K; Kawanishi T; Tsuchida J; Nakamoto Y; Nakao K; Yanagita M; Mukoyama M; Mori K
Sci Rep; 2017 Nov; 7(1):15501. PubMed ID: 29138470
[TBL] [Abstract][Full Text] [Related]
38. Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant.
Yamada Y; Miyamoto T; Kashima H; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Shiozawa T
Free Radic Res; 2016; 50(4):414-25. PubMed ID: 26729415
[TBL] [Abstract][Full Text] [Related]
39. Inverse Regulation of Lipocalin-2/24p3 Receptor/SLC22A17 and Lipocalin-2 Expression by Tonicity, NFAT5/TonEBP and Arginine Vasopressin in Mouse Cortical Collecting Duct Cells mCCD(cl.1): Implications for Osmotolerance.
Probst S; Scharner B; McErlean R; Lee WK; Thévenod F
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671521
[TBL] [Abstract][Full Text] [Related]
40. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.
Kim SL; Lee ST; Min IS; Park YR; Lee JH; Kim DG; Kim SW
Cancer Sci; 2017 Nov; 108(11):2176-2186. PubMed ID: 28859238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
